Dow, S&P 500, Nasdaq Futures Hold Steady as Nvidia Tumult Deepens

Image source: AI-generated image with OpenAI

US stock futures held steady on Friday as a bumpy week didn't prevent the major averages from being on pace for weekly gains.

Futures on the Dow Jones Industrial Average (YM=F) rose 0.1%, while those on the S&P 500 (ES=F) gained 0.2%. Nasdaq-100 futures (NQ=F) climbed 0.1%.

While stocks slipped on Thursday, they have largely held firm against a series of tremors, from Nvidia (NVDA) CEO Jensen Huang stepping down to rising oil prices and a sell-off in government bonds.

Nvidia stock recovered on Friday as the fallout from Huang's affairs continued to unfold, raising the stakes for the company's third-quarter earnings next Tuesday. Chipmaker stocks declined further in premarket trading.

Oil prices were little changed, providing some relief after a spike in prices sparked Thursday's sell-off in bonds. As traders braced for an interest rate hike in December, the 10-year Treasury yield (^TNX) reached 5.10% on Thursday, its highest level since October.

On the economic calendar, the producer price index readings will provide a gauge of wholesale inflation in October. Yahoo Finance reports.

🖥️ Applied Materials Sees Another Record Year in 2027

Applied Materials, Inc. (NASDAQ: AMAT) stock traded mostly flat in Friday’s premarket session after the semiconductor equipment maker reported strong fourth-quarter results and highlighted surging artificial intelligence demand.

Applied Materials expects global cloud capital spending to surge more than 50% in 2027, exceeding $1 trillion.

Management said the rapid expansion of AI infrastructure is fueling demand for advanced chips and semiconductor manufacturing equipment, positioning the company for another record year.

Applied Materials said its monthly AI token consumption grew more than 50-fold in 2026 as employees expanded their use of AI tools, with further growth expected in 2027. Benzinga reports.

🤖 Cerebras (CBRS) Stock Is Trending Pre-Market: Here's Why

Cerebras Systems Inc. (NASDAQ: CBRS) shares are trending on Friday.

Shares of the California-based artificial intelligence infrastructure and semiconductor company jumped 19.39% to $116.70 in premarket trading on Friday, following the release of third-quarter results and a raised full-year revenue outlook.

On Thursday, Cerebras reported a third-quarter loss of 67 cents per share, wider than the analyst estimate of a 14-cent loss, missing expectations by 378.6%.

GAAP revenue came in at $210.8 million, slightly below the $214.93 million estimate. However, the company’s adjusted core revenue reached $230.9 million, beating the $214.7 million LSEG consensus estimate, according to Reuters.

The positive sentiment around the stock appears to be driven by the company raising its fiscal 2026 revenue forecast to between $940 million and $960 million. Benzinga reports.

🧠 NeuroPace Shares Plunge 33.61% After-Hours: Here's What Investors Should Know

NeuroPace, Inc. (NASDAQ: NPCE) shares fell 33.61% to $7.98 in after-hours trading on Thursday after the company reported third-quarter revenue below analyst estimates and lowered its full-year 2026 revenue guidance.

NeuroPace is a medical device company focused on developing treatments for people living with epilepsy. Its RNS System delivers personalized, responsive treatment at the source of seizures.

NeuroPace reported third-quarter revenue of $23.1 million, down 1.1% from $23.4 million a year earlier and below analyst estimates of $27.14 million, representing a 14.9% miss. RNS System revenue increased 1.4% year over year to $22.9 million. Benzinga reports.

🧬 Candel Therapeutics Shares Tumble 39% After-Hours: Here's Why

Candel Therapeutics Inc. (NASDAQ: CADL) shares fell 39.09% to $5.11 in after-hours trading on Thursday after the company reported a wider third-quarter loss and said it currently plans to submit its prostate cancer regulatory application in mid-2027, pending ongoing discussions with the FDA.

The clinical-stage biopharmaceutical company focuses on developing immunotherapies for cancer patients.

Candel reported a net loss of $21.9 million for the third quarter of 2026, compared with a net loss of $11.3 million in the same quarter last year. Benzinga reports.

🏢 Merlin (MRLN) Stock Jumps Over 54% After Hours

Merlin Inc. (NASDAQ: MRLN) shares surged 54.50% to $1.49 after the bell on Thursday, following the announcement of third-quarter results, with earnings per share topping analyst estimates by 227.6%.

The results covered the quarter ended Sept. 30. The stock had closed at $0.96 on Nov. 12, down 4.51%. Revenue for the period came in at $3.46 million, beating the expected $2.19 million by 58.3%. Benzinga reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) MOD: Modine Manufacturing Company
Total gain: +31.57%

2) VTSI: VirTra, Inc.
Total gain: +31.30%

3) BKHA: Black Hawk Acquisition Corporation
Total gain: +20.74%

4) LFTO: Liftoff Mobile, Inc.
Total gain: +19.83%

5) SLS: SELLAS Life Sciences Group, Inc.
Total gain: +16.06%

The closing price of the top three market percent gainers trading near or above $2 on Nov 12.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET). Stock Analysis reports.

1) POAS: Phaos Technology Holdings (Cayman) Limited
Total gain: +234.18%

The stock appeared to be moving on no notable news.

2) XLAB: Exascale Labs Holdings Inc.
Total gain: +118.27%

The stock appeared to be moving on no notable news.

3) ADXN: Addex Therapeutics Ltd
Total gain: +83.04%

The company announced that its spin-out company, Neurosterix, has closed a $105 million Series B financing from a syndicate of leading life science investors. Addex did not participate in the financing and its equity interest now represents 8.5% of the issued capital at a valuation of $18.6 million. GlobeNewswire reports.

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

MUFG

Mitsubishi UFJ Finl Gr

Q2 2026

Before Market Open

Estimate: 0.450

Actual: 0.457

ARAI

Arrive AI

Q3 2026

Before Market Open

Estimate: -3.840

Actual: N/A

CNSY

Cerenome

Q3 2026

After Market Close

Estimate: -1.020

Actual: N/A

Time (ET) / Report / Period

• 8:30 AM / PPI / Oct.
• 8:30 AM / Ex-Food & Energy PPI, M/M% / Oct.
• 8:30 AM / PPI,Y/Y% / Oct.

“Past performance increases confidence more than ability.”

— Morgan Housel

Sourced in: Rules, Truths, Beliefs — Collaborative Fund

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.

Copyright © TradeZero 2026. All rights reserved.